Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

61509 1497862462HCLSReviewTaiwanJune2017.pdf
Energy Boardroom

Some cancer docs still bill heavily for Amgen's Epogen despite safety questions

23.06.2014 / Fierce Pharma

Many cancer doctors have cut back on their use of Amgen&#39;s anemia drug Epogen–also sold as Procrit by Johnson &amp; Johnson–because of safety questions that arose over the past few years. But as <em>The Wall Street Journal </em>reports, one Florida doctors&#39; group still administers the drug in quantity, accounting for one-sixth of related Medicare charges in 2012.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: